Prosecution Insights
Last updated: October 26, 2026
Application No. 18/827,588

METHODS AND SYSTEMS FOR ASSESSING VISUAL PROCESSING SPEED AND ACCURACY IN VIRTUAL ENVIRONMENTS

Non-Final OA §101
Filed
Sep 06, 2024
Examiner
DIETRICH, JOSEPH M
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Zenni Optical Inc.
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
768 granted / 947 resolved
+11.1% vs TC avg
Moderate +9% lift
Without
With
+8.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
44 currently pending
Career history
1003
Total Applications
across all art units

Statute-Specific Performance

§101
2.6%
-37.4% vs TC avg
§103
48.9%
+8.9% vs TC avg
§102
20.8%
-19.2% vs TC avg
§112
13.1%
-26.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 947 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1 – 20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Step 1 Claim 1 is a process. Claim 19 is a manufacture. Claim 20 is a machine. Step 2A, Prong One The claim(s) recite(s) an abstract idea: a mental process and/or a mathematical concept. Claim 1 recites the limitations: determining a sequence of 3D gaze positions of the eyes in the 3D virtual environment based on the sequence of eye images, and determining a visual processing performance factor for the user based on the sequence of stimulation positions and the sequence of 3D gaze positions. This is merely observing two sets of special data and evaluating them to produce a performance score. That evaluation can be performed in the human mind, or with pen and paper. This is the same class of abstract idea as collecting physiological or sensor data and calculating diagnostic or performcae metrics from it. Step 2A, Prong Two The claims do not integrate the abstract idea into a practical application. The additional elements are recited at a high level of generality. Displaying stimuli in a 3D virtual environment is insignificant extra-solution activity. Step 2B The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception. AN HMD with a processor, a memory, a displayed 3D environment, on-screen stimuli, and cameras that capture eye images are well-understood, routine, and conventional in VR vision testing and HMD eye tracking. Using those conventional tools to collect stimulus locations and gaze locations is an ordinary application of the abstract idea on a generic computer. Claims 19 and 20 add only a CRM and a system comprising an HMD, processors, and memory. These are generic components. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Sinha et al. (US PGPUB 2024/0197168) teaches a VR headset-based electronic system that can be used to perform visual tests. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSEPH M DIETRICH whose telephone number is (571)270-1895. The examiner can normally be reached Mon - Fri 8:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSEPH M DIETRICH/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Sep 06, 2024
Application Filed
Oct 05, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758774
METHODS AND SYSTEMS FOR GLUCOSE REGULATION
6y 2m to grant Granted Oct 13, 2026
Patent 12751826
SMART IMPLANTS FOR PERIPROSTHETIC JOINT INFECTION
3y 1m to grant Granted Oct 06, 2026
Patent 12728267
AUTOMATING BOLUS STIMULATION THERAPY FROM LEARNED USAGE
3y 2m to grant Granted Sep 08, 2026
Patent 12728260
SYSTEMS AND METHODS FOR NERVE CONDUCTION BLOCK
2y 12m to grant Granted Sep 08, 2026
Patent 12714856
IMPLANTABLE ELECTRICAL STIMULATION (IES) SYSTEM AND A METHOD THEREOF
3y 3m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
90%
With Interview (+8.8%)
3y 0m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 947 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month